The 2017 STAR (Successfully Targeting Advocacy Relations) Report, a market intelligence research report developed by MK&A and The Brooks Group, takes a deep dive into a comprehensive range of programmatic, policy, and reputational factors that drive best-in-class patient advocacy.
The report provides important insights from more than 150 patient groups and professional organizations across 17 therapeutic areas on critical elements of patient advocacy, emerging issues and how well industry is meeting the needs of patient communities.
The 2017 STAR Report eliminates development of patient advocacy strategies and programs in a vacuum and provides a comprehensive view into what makes the patient groups and communities tick, across the therapeutic/disease areas and categories of greatest importance to the pharma industry.
With the 2017 STAR Report:
The 2017 STAR Report can help pharma organizations of every size and type take a key step to becoming more patient-centric
Order your 2017 STAR Report today. To get more information about the 2017 STAR Report and answer any questions you may have, please contact Sharon Dion at firstname.lastname@example.org or at +1 212 620 2774.
MK&A publications create enhanced understanding, knowledge-sharing, better connections and more collaborative relationships between patient advocacy groups and communities and pharma/life sciences companies.
MK&A publications help foster increased patient group perspectives into the drug development process, supporting pharma/life sciences companies seeking to bring to market better and more effective therapies.